Call Us: Direct line: +91 8448 444 095 Toll free: 1-800-222-434 E-Mail

Taj India Products.

TAJ PHARMA INDIA / Product / CEFOZONE 1 g. (Sulbactam & Cefoperazone For Injection)

CEFOZONE 1 g. (Sulbactam & Cefoperazone For Injection)

Generic Name

Sulbactam & Cefoperazone For Injection

Brand Name


Dosage Form


Strength and Dosage


Therapeutic Category

Patient Information Leaflet

Summary of Product Characteristics pdfIcon


The combination of Sulbactum and Cefoperazone is active against all organisms sensitive to cefoperazone. In addition, it demonstrates synergistic activity (up to 4-fold reduction in the minimum inhibitory concentrations for the combination versus those for each component) in a variety of organisms.

It is indicated for the treatment of the following infections when caused by susceptible organisms:
i. Respiratory tract infections (upper and lower)
ii. Urinary tract infections (upper and lower)
iii. Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
iv. Septicaemia
v. Meningitis
vi. Skin and soft tissue infections
vii. Bone and joint infections
viii. Pelvic inflammatory disease, endometritis, gonorrhoea, and other infections of the genital tract

Combination Therapy
Because of the broad spectrum of activity of Sulbactum/ Cefoperazone, most infections can be treated adequately with this antibiotic combination alone. However, CEFOZONEmay also be used concomitantly with other antibiotics if such combinations are indicated. If an aminoglycoside is used, renal function should be monitored during the course of therapy.


It is contraindicated in patients with a known allergy to penicillins, sulbactam, cefoperazone, or any of the cephalosporins.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam or cephalosporin therapy. These reactions are more apt to occur in individuals with a history of hypersensitivity reactions to multiple allergens. If an allergic reaction occurs, the drug should be discontinued and the appropriate therapy instituted.
As with other antibiotics, overgrowth of non-susceptible organisms may occur during the prolonged use of CEFOZONE. It has not been extensively studied in premature infants or neonates. Therefore, in treating premature infants and neonates, the potential benefits and possible risks involved should be considered before instituting therapy.
Drug Interactions
A reaction characterized by flushing, sweating, headache and tachycardia has been reported when alcohol was ingested during and as late as the fifth day after Cefoperazone administration. A similar reaction has been reported with certain other cephalosporins and patients should be cautioned concerning ingestion of alcoholic beverages in conjunction with administration of CEFOZONE. For patients requiring artificial feeding orally or
parenterally, solutions containing ethanol should be avoided.

Hepatic Impairment
In severe hepatic dysfunction, therapeutic concentrations of Cefoperazone are obtained in the bile and only a 2-to 4-fold increase in the half-life is seen. Dose modification may be necessary in case of severe biliary obstruction, severe hepatic disease or in case of renal dysfunction coexistent with either of those conditions.

There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Caution should be exercised when CEFOZONE is administered to a nursing mother.


The usual adult dose of the combination is 2 to 4 g/day (i.e, 1-2 g/day each of Cefoperazone and Sulbactam) given IV or IM in equally divided doses every 12 hours.
In severe or refractory infections the daily dosage may be increased to 8g (i.e, 4g/day each of Cefoperazone and Sulbactam) given IV in equally divided doses every 12 hours. The recommended maximum daily dosage of Sulbactam is 4g (8g of the combination).

The usual dosage in children is 40-80mg/kg/day (20 to 40 mg/kg/day each of Cefoperazone and Sulbactam) every six to twelve hours. In serious or refractory infections, these dosages may be increased up to 240mg/kg/day (160 mg/kg/day cefoperazone activity). Doses should be administered in two to four equally divided doses.

Intravenous Administration
For intravenous infusion, each vial of CEFOZONE should be reconstituted with the appropriate amount of 5% Dextrose, 0.9% Sodium Chloride Injection or Sterile Water for Injection, then further diluted to 20 mL with the same solution, and followed by administration over 15 to 60 minutes. Lactated Ringer’s Solution is a suitable vehicle for intravenous infusion, but it is not, however, for initial reconstitution.

For intravenous injection, each vial should be reconstituted as above and administered over a minimum of 3 minutes.


CEFOZONE is generally well-tolerated. Majority of adverse events are of mild or moderate severity and are tolerated with continued treatment. The most frequent side effects observed with CEFOZONE have been gastrointestinal. Others include dermatologic reactions, headache, injection pain, chills, and
anaphylactic reactions.


Keep out of the reach and sight of children.
Do not use CEFOZONE after the expiry date which is stated on the carton and on the vial label. The expiry date refers to the last day of that month.
Do not store above 25°C. Do not refrigerate or freeze.
Reconstituted Solution
Reconstituted solution is stable for 7 days at 2-8°C and for 24 hours at 8-25°C.
For single use only, Discard any unused contents.
After reconstitution, the solution should be used immediately.
Do not use CEFOZONE if you notice signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.


What CEFOZONE contains
– The active substance is Sulbactam and Cefoperazone
Each vial of CEFOZONE contains total 1g of Sulbactam and Cefoperazone
Also available in strengths of 1.5g and 2g

What CEFOZONE looks like and contents of the pack
CEFOZONE is a dry powder for solution for injection.
It is supplied in a Glass vial with diluent in a carton

Additional Information

If you are a distributor, please inquire with us about product , importing and/or marketing our products in your country or region. If you are a consumer, don’t hesitate to contact us about more information for this product.

To inquire more about cost effective Taj Brands products, hospital imports, non-available life saving products, please contact us.

The most common markets for this product include the following state . Please inquire with us if your state is not listed:

North India : Jammu & Kashmir ,Himachal Pradesh,Uttar Pradesh ,Uttaranchal , Punjab ,Haryana.
South India : Kerala, Karnataka ,Tamil Nadu,Andhra Pradesh.
East India : Assam ,Manipur, Meghalaya,West Bengal ,Orissa,Sikkim ,Mizoram, Tripura
West India : Goa ,Gujarat ,Rajasthan ,Maharashtra
Central India : Madhya Pradesh, Chattisgarh

Back to Top